One study showed that CD38 positivity of blast cells correlated with the presence of ETV6::RUNX1 rearrangement, and a higher number of B-ALL cells with low CD38 expression could be an early indicator of relapse risk [29,30]. This evidence concerns the gene CD38 and acute lymphoblastic leukemia.